V. Lallemand-Breitenbach
发表
H. de Thé,
V. Lallemand-Breitenbach,
2010,
Cold Spring Harbor perspectives in biology.
V. Lallemand-Breitenbach,
H. Thé,
Jun Zhu,
2001,
Oncogene.
H. de Thé,
V. Lallemand-Breitenbach,
Umut Sahin,
2022,
Cells.
H. de Thé,
F. Jollivet,
V. Lallemand-Breitenbach,
2016,
Methods in molecular biology.
P. Freemont,
R. Hay,
H. de Thé,
1999,
Journal of cell science.
P. Bénit,
T. Mak,
J. Soulier,
2021,
Cancer discovery.
Y. Kfoury,
H. de Thé,
Zeina Dassouki,
2015,
Blood.
H. de Thé,
V. Lallemand-Breitenbach,
Umut Sahin,
2014,
The Journal of pathology.
P. Cossart,
M. Nahori,
H. de Thé,
2017,
mBio.
B. Goud,
F. Perez,
C. Poüs,
2004,
Journal of Biological Chemistry.
H. de Thé,
R. González-Prieto,
A. Vertegaal,
2022,
Nature Communications.
V. Lallemand-Breitenbach,
H. Thé,
L. Pérès,
2016,
Science Signaling.
JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML
F. Pasquier,
W. Vainchenker,
J. Villeval,
2020,
The Journal of experimental medicine.
H. de Thé,
M. Niwa-Kawakita,
M. Le Bras,
2017,
The Journal of experimental medicine.
M. Lei,
B. Raught,
R. Nasr,
2008,
Nature Cell Biology.
Saijuan Chen,
Zhu Chen,
H. de Thé,
2018,
Nature Communications.
S. Kogan,
H. de Thé,
V. Lallemand-Breitenbach,
2005,
Nature reviews. Cancer.
H. Dombret,
M. Lanotte,
S. Kogan,
2002,
The Journal of experimental medicine.
V. Lallemand-Breitenbach,
H. Thé,
Jun Zhu,
2002,
Nature Reviews Cancer.
Jian-Hua Tong,
Guang-Biao Zhou,
Marion Jeanne,
2010,
Science.
H. de Thé,
V. Lallemand-Breitenbach,
Jun Zhu,
2012,
Trends in molecular medicine.
Paul Freemont,
Pier Paolo Pandolfi,
P. Pandolfi,
2001,
The Journal of experimental medicine.
A. Vincent-Salomon,
M. Stern,
G. Raposo,
2019,
Cell metabolism.
H. de Thé,
M. Le Bras,
V. Lallemand-Breitenbach,
2012,
The Journal of cell biology.
I. Weissman,
J. Bishop,
S. Kogan,
2001,
The Journal of experimental medicine.
H. de Thé,
V. Lallemand-Breitenbach,
Hugues de Thé,
2018,
Current opinion in cell biology.
P. Pandolfi,
R. Nasr,
P. Rousselot,
2008,
Nature Medicine.
H. de Thé,
Alessia Zamborlini,
F. Jollivet,
2014,
Nature Communications.
N. Setterblad,
H. de Thé,
O. Faklaris,
2014,
The Journal of cell biology.
B. Raught,
H. de Thé,
M. Koken,
2010,
Cancer cell.
S. Kogan,
H. de Thé,
A. Janin,
1999,
The Journal of experimental medicine.
H. de Thé,
V. Lallemand-Breitenbach,
Umut Şahin,
2014,
Nucleus.
S. Kogan,
V. Lallemand-Breitenbach,
H. Thé,
2005,
Nature Reviews Cancer.
Yuki Takahashi,
V. Lallemand-Breitenbach,
H. Thé,
2004,
Oncogene.
P. Pandolfi,
T. Regad,
H. de Thé,
2001,
The EMBO journal.
H. de Thé,
R. González-Prieto,
A. Vertegaal,
2021,
bioRxiv.
M. Niwa-Kawakita,
V. Lallemand-Breitenbach,
H. Thé,
2017,
Seminars in cell & developmental biology.
Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner
R. Mahieux,
A. Bazarbachi,
V. Lallemand-Breitenbach,
2018,
Oncogene.
R. Nasr,
H. de Thé,
V. Lallemand-Breitenbach,
2009,
Clinical Cancer Research.
H. de Thé,
V. Lallemand-Breitenbach,
2013,
Blood.
V. Lallemand-Breitenbach,
H. Thé,
2006,
Cell.
H. de Thé,
R. González-Prieto,
A. Vertegaal,
2022,
Nature Communications.
H. de Thé,
M. Le Bras,
V. Lallemand-Breitenbach,
2012,
The Journal of cell biology.
A. Carracedo,
H. de Thé,
V. Lallemand-Breitenbach,
2017,
Antioxidants and Redox Signaling.
H. de Thé,
V. Lallemand-Breitenbach,
2010,
Blood.
H. de Thé,
M. Le Bras,
V. Lallemand-Breitenbach,
2012,
The Journal of cell biology.
V. Lallemand-Breitenbach,
M. Abou-Ghali,
2024,
Nucleus.